Literature DB >> 11486627

[Urinary concentration of collagen metabolites in endoprosthesis loosening].

W C Witzleb1, M Menschikowski.   

Abstract

Aseptic loosening is the most common long-term complication in arthroplasty. Loosening is in every case associated with bone resorption at the interface that leads to bone defects and complicates the revision. The diagnosis of aseptic loosening is based on clinical and radiological evaluation. Especially in clinically asymptomatic cases an early diagnosis with these methods is difficult. In our study we wanted to evaluate the diagnostic value of biochemical markers of the bone resorption in aseptic loosening. We compared 58 patients with proven implant loosening during surgery with 67 patients without clinical or radiological signs of loosening. We measured the crosslinks pyridinoline and hydroxypyridinoline in urine samples. In contrast to Schneider et al. [increased urinary crosslink levels in aseptic loosening of total hip arthroplasty, J. Arthroplasty 1995; 13 (6): 687-692] we found no significant differences between loose and asymptomatic hip or knee prosthesis. Also no correlation between the size of the acetabular defects of loose hip implants and the urinary crosslink excretion was measurable. Our results show no or only little diagnostic value of the urinary crosslinks pyridinoline and deoxypyridinoline in aseptic loosening of total hip and knee arthroplasty.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11486627     DOI: 10.1055/s-2001-16327

Source DB:  PubMed          Journal:  Z Orthop Ihre Grenzgeb        ISSN: 0044-3220


  2 in total

1.  Is tartrate-resistant acid phosphatase 5b a potent bio-marker for late stage aseptic implant loosening?

Authors:  Gerrit Steffen Maier; Christian Eberhardt; Marco Strauch; Konstantinos Kafchitsas; Andreas A Kurth
Journal:  Int Orthop       Date:  2014-08-01       Impact factor: 3.075

2.  Biochemical markers of bone turnover in aseptic loosening in hip arthroplasty.

Authors:  Nikolaus A Streich; Tobias Gotterbarm; Martin Jung; Ulrich Schneider; Christian Heisel
Journal:  Int Orthop       Date:  2007-12-15       Impact factor: 3.075

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.